News
In defiance of the weak USDollar Lobeck Medical AG will terminate the year 2008 as expected. „We can fulfill our turnover expectations “, announce Andreas Dornbierer of the board of directors, not without pride that the order books with more than 1.3 million US Dollar form a good basis for the future. „This is more than satifactory. “
Not only because of the good figures the company sees itself confirmed in its strategy to offer consistently high-quality and manufactured in Switzerland products. Also the MEDICA fair of this year in Düsseldorf, which closed its gates just recently on 22 November, contributes its part to it: „possible distributors digress after a relatively short time from cheap manufacturers from Asia“, reports Dornbierer the tenor of the fair, „and pretty often we can establish our „made in Switzerland“ products in potential sales markets because of this.“
In particular the internal brandname „MediSmart of Switzerland® “significantly gained in importance, under which the Lobeck products are sold world-wide - as a synonym for a outstanding price performance ratio. Also it might have to be owed to the good reputation resulting from it, that the sales department could win new customers in the last months in some further countries. Recently Lobeck could win a large order (tender), via exclusive distribution partner, which will bring the company more than five million US Dollar turnover within the next five years. Dornbierer: „Singleorders of this size confirm to us that we are on the right way with our strategy „Swiss quality and content customers “. Therefore Lobeck focus further intensive and selectively on potential sales markets, among others also on the former Eastern block countries inclusive Russia. “
After an experienced hard start also the range of the In-Vitro-diagnostics-hometest products proves as a positive investment. After well one year's positive test phase, we may anticipate, among other things, from just one distribution partner only, on an annual delivery volume of approximately one million pieces MediSmart pregnancy tests for 2009.
Due to this development, the managements investment planned since this spring to manufacture and packing in-house is further advanced so that in future the entire process can be conducted internally and thus will be more efficiently and economically, than through external sub-contractors in Switzerland so far.
Such achievements, also with the IVD hometest product range, confirm the longer the more that we are slowly but however reliably established worldwide with our productbrand „MediSmart of Switzerland®“, which is registered in over 60 countries.
"Bienvenidos a Lobeck Medical Ltd"
As of today, our homepage is also available in Spanish language! All our Spanish speaking customers can now "surf" through lobeck.com.
Dallas/USA -
Frick/Switzerland, 6th of June 2008
Allarae Health Care Inc., Dallas/USA
(OTC.ALHI.PK) and Lobeck Medical AG, Frick/ Switzerland (FRANKFURT Stock
Exchange – ISIN CH0025477065 / Symbol 34L) are pleased to announce an agreement
on a long- term Joint Venture.
Both companies are active in the field of rapid
screening tests. Allarae Health Care Inc. is a strong R+D company focusing on
to the development of innovative products in the medtech industry. Lobeck Medical
AG has developed several innovative products in the range of diabetes (blood
glucose meters) and In Vitro Diagnostic
test kits for pregnancy, ovulation, female menopause and colon cancer. Lobeck
Medical AG is focusing on the further development of the global distribution channel.
Together the two companies will launch several
innovative new products in the field of early cancer detection such as breast
cancer monitoring, strep throat detection, prostate PSA and flu virus screening.
All manufacturing of the products will be accomplished at Lobeck Medical
Switzerland under strict medical product quality procedures. FDA and CE
approval has already been obtained for several tests which are ready for
immediate global sale under the worldwide protected brand name “MediSmart of
Switzerland®”.
A joint subsidiary Lobeck Medical Inc. will be opened in the State Nevada in addition to a sales office in Dallas. The joint subsidiary will be
responsible for the distribution in North America as well as for the further
FDA approval process.
Under the main provisions of the new agreement,
Allarae will make available, a comprehensive software system for test result
tracking and monitoring under the “MediSmart of Switzerland®” brand. The
software will integrate all the test kits and blood glucose meters into a
central data vault and tracking network, thereby creating a unique,
first-to-market international offering. These new products, among others, will
be presented at the worlds leading medical trade fair MEDICA in November 2008
in Düsseldorf/Germany.
Mr. Phillip Matteis, Allarae’s CEO said today,
“This is a hallmark agreement for both companies… It is very important that
families and individuals have the tools available to find out if they have any
major health conditions at the earliest possible time… health problems such as
cancer can go undetected for years until it is too late for a favorable
outcome… the combined growing line of kits and software will bring affordable
solutions to an international market like never before… because of today’s
complex healthcare environment, everyone must take personal responsibility to
monitor their health on a regular basis…”
By combining the personal testing and
monitoring kits and software of Allarae and Lobeck under the joint distribution
umbrella, both companies will realize an enriched product offering, including
multi-national data, and a unique opportunity worldwide which the management
team believes will be a significant driver for increased shareholder value in
both companies.
We have moved in to our new offices. Our new address is:
Lobeck Medical Ltd
Industriestrasse 26
5070 Frick / Switzerland
Telephone/Fax and E-mail remain the same.


MediSmart of Switzerland® blood glucose meters are available in Albania since 2006. Today Lobeck Medical reports next delivery of glucometers to Albania. The same time Lobeck Medical receives first order for its IVD hometest products.
Lobeck Medical reaches another milestone in the development of its brandnew MediSmart® SAPPHIRE blood glucose meter which is in the final stage. The glucose meter already has successfully passed all the clinical tests. The official launch (ready for delivery) is begining of May 2008.
Link to the new blood glucose meter Sapphire
Lobeck Medical reports expansion of its distribution network to Lybia, Azerbaijan and the Philippines. Especially the Lybian and Philippines diabetes markets promise a high potential for SWISS MADE glucometers, which is approved by first deliveries into these markets and the very positive feedback.
Lobeck Medical receives continous orders from it's Sri Lankan distribution partner for the MediSmart of Switzerland® blood glucose meter system, which successfully was launched and established on the market since beginning of 2007.
The continuous repeat orders for Belgium/Luxemburg and the Netherlands
confirm that we made the break-through with our IVD hometest products.
Shortly our blood glucose meter system will also be available on the
Lebanese and Iceland market. Expectations in these markets are limited,
on the other hand it is important for Lobeck Medical to mark presence
in all countries around the globe.
Brazil is a complicated market (in particular concering the customs
import process). After our blood glucose meter system of the first
delivery had an outstanding sale, new deliveries could be arranged
already. Due to the enormous size of the country, Lobeck Medical
evaluates to build up a further strong Importer/Distributor.
The company moves into a 1000 square meter factory building in April
2008 in Frick, Switzerland. The reason for this removal lies in the
fact that the Lobeck Medical aims to increase the manufacturing depth
for all product segments. The management promises itself an
optimization of the margins on one hand and to improve the quality
control on permanent basis on the other hand.
Besides of many other
advantages this change will also offer the possibility to improve the
productionflexibility. Thus the company expects to be able to increase
the profitability, because of the verticalization of the manufacturing
process.
Also the first order to Brasil has been released and delivered just
these days. Brasil blood glucose meter market is one of the worlds most
fast growing markets with a huge potential but strict registration
procedure, which we recently passed successfully.
09.11.2007:
China
First order to our exclusive distribution partner DKSH (Diethelm
Keller Siber Hegner) China is released and delivered successfully.
Distribution of MediSmart® Diamond glucose meter system through their
immense sub-dealer system will start in China from now.
Second delivery of IVD hometest products left for Belgium/Netherlands/Luxembourg market these days.
We recently received second order from Kuwait, where our MediSmart®
DIAMOND blood glucose meter system has been successfully installed by
our exclusive distributor in the local market as Swiss quality product.
News archive
^ to the top